Developing Topics.

Alzheimers Dement

Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.

Published: December 2024

Background: It is known that atipical aging in DS is related to a high risk of early dementia, with neuropathological charactheristics compatible with Alzheimer´s disease (AD). Changes in functional mobility are expected throughout the aging process, with impairments in motor performance, involving balance and gait. Growing evidence suggests that sleep disruption may also accelerate the progression to symptomatic Alzheimer's disease (AD) in this population. Therefore, it is mandatory to assess sleep quality and diagnose sleep-disordered breathing, especially obstructive sleep apnea (OSA), associated with DS, to improve cognition and quality of life, preventing related comorbidities.

Method: We evaluated 66 individuals with DS (≥20 years), divided into 3 groups: stable cognition, prodromal dementia, and Alzheimer's disease. Each individual was evaluated with the Performance-Oriented Mobility Assessment (POMA) protocol, Polysomnography, and Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities interview adapted for adults with DS (CAMDEX-DS).

Result: The logistic regression model with the stepwise backward technique, with the initial model including age, gender, body mass index (BMI), degree of intellectual disability, and apnea-hypopnea index (AHI), showed that gait performance in POMA are independent factors associated with the diagnosis of control and dementia (POMA p < 0.005). All cognitive domains were correlated with OSA, but only orientation had a significant correlation (p-value 0.268). We did not find a difference in OSA scores among POMA.

Conclusion: The POMA results indicate that those with AD have worse gait performance and a higher risk of falls relative to those with dementia and stable cognition. There was no evidence of correlation between gait speed and OSA, which may have been influenced by the sample size (n:17). Further longitudinal studies with larger samples are needed to confirm our results.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.094955DOI Listing

Publication Analysis

Top Keywords

alzheimer's disease
8
stable cognition
8
gait performance
8
developing topics
4
topics background
4
background atipical
4
atipical aging
4
aging high
4
high risk
4
risk early
4

Similar Publications

TREM2 is a signaling receptor expressed on microglia that has emerged as an important drug target for Alzheimer's disease and other neurodegenerative diseases. While a number of TREM2 ligands have been identified, little is known regarding the structural details of how they engage. To better understand this, we created a protein library of 28 different TREM2 variants that could be used to map interactions with various ligands using biolayer interferometry.

View Article and Find Full Text PDF

Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer's disease.

Fluids Barriers CNS

January 2025

Sanders-Brown Center on Aging, College of Medicine, University of Kentucky, 760 Press Ave, 124 HKRB, Lexington, KY, 40536-0679, USA.

Background: Blood-brain barrier dysfunction is one characteristic of Alzheimer's disease (AD) and is recognized as both a cause and consequence of the pathological cascade leading to cognitive decline. The goal of this study was to assess markers for barrier dysfunction in postmortem tissue samples from research participants who were either cognitively normal individuals (CNI) or diagnosed with AD at the time of autopsy and determine to what extent these markers are associated with AD neuropathologic changes (ADNC) and cognitive impairment.

Methods: We used postmortem brain tissue and plasma samples from 19 participants: 9 CNI and 10 AD dementia patients who had come to autopsy from the University of Kentucky AD Research Center (UK-ADRC) community-based cohort; all cases with dementia had confirmed severe ADNC.

View Article and Find Full Text PDF

Neuropathological contributions to grey matter atrophy and white matter hyperintensities in amnestic dementia.

Alzheimers Res Ther

January 2025

Laboratory for Clinical Neuroscience, Center for Biomedical Technology, Universidad Politécnica de Madrid, IdISSC, Crta M40, km38, Madrid, 28223, Spain.

Background: Dementia patients commonly present multiple neuropathologies, worsening cognitive function, yet structural neuroimaging signatures of dementia have not been positioned in the context of combined pathology. In this study, we implemented an MRI voxel-based approach to explore combined and independent effects of dementia pathologies on grey and white matter structural changes.

Methods: In 91 amnestic dementia patients with post-mortem brain donation, grey matter density and white matter hyperintensity (WMH) burdens were obtained from pre-mortem MRI and analyzed in relation to Alzheimer's, vascular, Lewy body, TDP-43, and hippocampal sclerosis (HS) pathologies.

View Article and Find Full Text PDF

Brain organoid models have greatly facilitated our understanding of human brain development and disease. However, key brain cell types, such as microglia, are lacking in most brain organoid models. Because microglia have been shown to play important roles in brain development and pathologies, attempts have been made to add microglia to brain organoids through co-culture.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!